Business / Finance

RSS

Centric Health second quarter revenue increases 111% to $33.6 million

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced financial results for the second quarter ended June 30, 2011.

11 Aug 2011

InVivo Therapeutics reports net loss of $1,370,000 for second quarter 2011

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

11 Aug 2011

Merck receives Oliver Wight Class A certification

Pharmaceutical and chemical giant Merck KGaA has been awarded Class A certification by Oliver Wight after dramatic improvements in service levels and a €15 million reduction in inventory, at its Darmstadt pharmaceutical production facility.

11 Aug 2011

BELLUS Health second quarter revenues increase to $719,000

BELLUS Health Inc. reported today its financial results for the second quarter ended June 30, 2011.

10 Aug 2011

SANUWAVE second quarter revenues increase 40%

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

10 Aug 2011

Accretive Health second quarter net income increases 118% to $8.6 million

Accretive Health, Inc., a leading provider of comprehensive end-to-end healthcare revenue cycle management services and population health management services infrastructure, today announced financial results for the quarter ended June 30, 2011.

10 Aug 2011

Winner Medical third quarter net sales increase 34% to $41.5 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.

10 Aug 2011

Protox reports net loss of $3.2 million for second quarter 2011

Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.

10 Aug 2011

Global endoscopy equipment market to reach $33.7 billion by 2016: New report

By 2016 it is believed that the global endoscopy equipment market will be worth in excess of $33.7 billion, growing at a CAGR of 6.4% over the reporting period, according to a new report available on companiesandmarkets.com.

10 Aug 2011

Moberg Derma receives first order for Emtrix from Walmart

The public company Moberg Derma AB has through its U.S. distributor Alterna LLC received a first order from the world's largest retail chain, Walmart, for Emtrix - its treatment of discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis.

10 Aug 2011

Orexo reports net revenues of MSEK 55.2 for second quarter 2011

OREXO: STRONG SALES INCREASE FOR ABSTRAL. For the period. Royalty revenues from Abstral sales in Europe rose to MSEK 30.4.

10 Aug 2011

In bid to calm markets, Obama urges deficit reduction approach that includes 'modest adjustments' to Medicare

As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.

10 Aug 2011

Enobia raises US$40M through private placement

Enobia Pharma Inc., a clinical stage biotech company focused on developing novel therapeutics for serious bone disorders, today announced that it has raised US$40 million through the private placement of approximately 13,724,000 shares of its common stock to new pharmaceutical and financial investors.

10 Aug 2011

New report: U.S. antiseptics and disinfectants market to reach $2.9B by 2016

In 2009, the disinfectant and antiseptic market was worth around $3.4 billion, but by 2010 had grown over 12%, to reach a value of $3.8 billion, according to a new report available from companiesandmarkets.com.

9 Aug 2011

Akela announces new corporate focus on PharmaForm

Akela Pharma, Inc. today announced a new strategic focus on its profitable pharmaceutical contract manufacturing business, PharmaForm, LLC.

9 Aug 2011

CIGNA launches new office and operations in Turkey

CIGNA, a leader in direct marketed supplemental health, life and accident insurance in the international marketplace, today announced the launch of a new office and operations in Turkey.

9 Aug 2011

Pharmasset declares two-for-one split of common stock

Pharmasset, Inc. announces that its Board of Directors declared a two-for-one split of Pharmasset's common stock, par value $0.001 per share, in the form of a 100% common stock dividend.

9 Aug 2011

TSO3 second quarter revenues increase to $703,000

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, posted its highest quarterly revenues in its second quarter of 2011.

9 Aug 2011

Simcere second quarter total revenue increases 0.3% to US$84.4 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended June 30, 2011.

9 Aug 2011

GTx reports revenue of $1.6 million for second quarter 2011

GTx, Inc. today reported financial results for the second quarter of 2011. The net loss for the quarter ended June 30, 2011 was $10.7 million compared with a net loss of $12.9 million for the quarter ended June 30, 2010.

9 Aug 2011